CVRx (CVRX) Income from Continuing Operations (2020 - 2026)
CVRx (CVRX) posted quarterly Income from Continuing Operations of 13120000.0 for Q1 2026, up 4.69% year-over-year from 12531912.3 in Q1 2025, and down 9.94% quarter-over-quarter from 11934000.0 in Q4 2025.
CVRx (CVRX) Income from Continuing Operations (2020 - 2026) Analysis & Trends
CVRx's Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 13120000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 4.69% year-over-year to 13120000.0; the TTM figure through Mar 2026 stood at 52660000.0 (down 2.14% YoY), while the FY2025 annual figure was 53306000.0, up 11.12% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 13120000.0, down from 11934000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 9011000.0 in Q3 2023, with the low at 22186000.0 in Q1 2024.
- The 5-year median for Income from Continuing Operations is 11651000.0 (2023), against an average of 12287235.29.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations tumbled 95.06% in 2024, then surged 37.95% in 2025.
- CVRx's Income from Continuing Operations stood at 10536000.0 in 2022, then increased by 14.43% to 9016000.0 in 2023, then dropped by 18.27% to 10663000.0 in 2024, then declined by 11.92% to 11934000.0 in 2025, then dropped by 9.94% to 13120000.0 in 2026.
- Business Quant data shows CVRX's Income from Continuing Operations at 13120000.0 in Q1 2026, 11934000.0 in Q4 2025, and 12870000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | CVRx | 76.50 Mn | 11.91 Mn | 13.72 Mn | -14.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.04 Mn |
| Mar 31, 2026 | -13.12 Mn |
| Dec 31, 2025 | -11.93 Mn |
| Sep 30, 2025 | -12.87 Mn |
| Jun 30, 2025 | -14.74 Mn |
| Mar 31, 2025 | -13.77 Mn |
| Dec 31, 2024 | -10.66 Mn |
| Sep 30, 2024 | -13.10 Mn |
| Jun 30, 2024 | -14.03 Mn |
| Mar 31, 2024 | -22.19 Mn |
| Dec 31, 2023 | -9.02 Mn |
| Sep 30, 2023 | -9.01 Mn |
| Jun 30, 2023 | -11.65 Mn |
| Mar 31, 2023 | -11.37 Mn |
| Dec 31, 2022 | -10.54 Mn |
| Sep 30, 2022 | -9.83 Mn |
| Jun 30, 2022 | -11.07 Mn |
| Mar 31, 2022 | -9.99 Mn |
| Dec 31, 2021 | -10.57 Mn |
| Sep 30, 2021 | -6.13 Mn |